NDC 63545-627

Caladium Seguinum

Caladium Seguinum

Caladium Seguinum is a Oral Pellet in the Human Otc Drug category. It is labeled and distributed by Hahnemann Laboratories, Inc.. The primary component is Dieffenbachia Seguine.

Product ID63545-627_de9b1a67-910c-08c4-e053-2995a90af7ce
NDC63545-627
Product TypeHuman Otc Drug
Proprietary NameCaladium Seguinum
Generic NameCaladium Seguinum
Dosage FormPellet
Route of AdministrationORAL
Marketing Start Date2022-05-09
Marketing CategoryUNAPPROVED HOMEOPATHIC /
Labeler NameHahnemann Laboratories, INC.
Substance NameDIEFFENBACHIA SEGUINE
Active Ingredient Strength500 [hp_C]/1
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 63545-627-01

200 PELLET in 1 VIAL, GLASS (63545-627-01)
Marketing Start Date2022-05-09
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Caladium Seguinum" or generic name "Caladium Seguinum"

NDCBrand NameGeneric Name
0220-1027Caladium seguinumDIEFFENBACHIA SEGUINE
0220-1031Caladium seguinumDIEFFENBACHIA SEGUINE
0220-1032Caladium seguinumDIEFFENBACHIA SEGUINE
0220-1034Caladium seguinumDIEFFENBACHIA SEGUINE
0220-1035Caladium seguinumDIEFFENBACHIA SEGUINE
0220-1036Caladium seguinumDIEFFENBACHIA SEGUINE
15631-0090CALADIUM SEGUINUMCALADIUM SEGUINUM
15631-0546CALADIUM SEGUINUMCALADIUM SEGUINUM
63545-622Caladium SeguinumCaladium Seguinum
63545-623Caladium SeguinumCaladium Seguinum
63545-624Caladium SeguinumCaladium Seguinum
63545-625Caladium SeguinumCaladium Seguinum
63545-626Caladium SeguinumCaladium Seguinum
63545-627Caladium SeguinumCaladium Seguinum
63545-628Caladium SeguinumCaladium Seguinum
63545-629Caladium SeguinumCaladium Seguinum
68428-271Caladium SeguinumDIEFFENBACHIA SEGUINE
71919-141Caladium seguinumDIEFFENBACHIA SEGUINE
69152-1166Caladium seguinum 200CCaladium seguinum

© 2022 FDA.report
This site is not affiliated with or endorsed by the FDA.